AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Twist Bioscience to Present at the 38th Annual J.P. Morgan Healthcare Conference

January 6, 2020 GMT

SAN FRANCISCO--(BUSINESS WIRE)--Jan 6, 2020--

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15th at 8:30 a.m. Pacific Time in San Francisco.

The presentation will be webcast live and can be accessed by visiting the “Presentations” page of the investor relations section of the company’s website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live event.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com:https://www.businesswire.com/news/home/20200106005310/en/

CONTACT: Investor Contact:

Argot Partners

Maeve Conneighton

212-600-1902

maeve@argotpartners.comMedia Contact:

Angela Bitting

925- 202-6211

media@twistbioscience.com

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH TECHNOLOGY NANOTECHNOLOGY GENETICS RESEARCH SCIENCE BIOTECHNOLOGY

SOURCE: Twist Bioscience Corporation

Copyright Business Wire 2020.

PUB: 01/06/2020 08:00 AM/DISC: 01/06/2020 08:01 AM

http://www.businesswire.com/news/home/20200106005310/en